B cell signaling and tumorigenesis

Hassan Jumaa1, Rudolf W Hendriks, Michael Reth

  • 1Institute for Biology III, Albert-Ludwigs University of Freiburg and Max Planck Institute for Immunobiology, 79108 Freiburg, Germany. jumaa@immunbio.mpg.de

Insights

Lymphocyte signaling pathways, including those involving Src and Abelson (Abl) kinases, are crucial for cell proliferation and differentiation. Understanding these pathways, particularly auto-inhibition and subcellular localization, is key to comprehending B cell development and tumorigenesis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Lymphocyte proliferation and differentiation are controlled by cell surface receptors and intracellular signaling proteins.
  • Kinases like Src and Abelson (Abl) were initially identified as oncogenes and are vital for signal transduction.
  • Understanding signaling pathways helps elucidate the link between specific proteins and tumorigenesis.

Purpose of the Study:

  • To review recent advancements in the molecular mechanisms of signaling pathways governing early B cell proliferation and differentiation.
  • To highlight the significance of auto-inhibition and subcellular localization in regulating B cell signaling.

Main Methods:

  • Review of current literature on B cell signaling pathways.
  • Analysis of molecular mechanisms underlying lymphocyte activation and regulation.
  • Focus on the roles of oncogene-derived kinases in signal transduction.

Main Results:

  • Identification of key signaling proteins and pathways controlling B cell development.
  • Elucidation of how receptor engagement triggers intracellular signal transmission.
  • Demonstration of the critical roles of auto-inhibition and subcellular localization in B cell signaling regulation.

Conclusions:

  • Molecular mechanisms of signaling pathways are essential for understanding lymphocyte function.
  • Auto-inhibition and subcellular localization are pivotal regulatory concepts in B cell signaling.
  • Insights into these pathways can advance our understanding of lymphocyte-related diseases and cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...